Merely miR210 in mesenchymal stem cells - One size fits all

Journal of Molecular Medicine

Volumn 90, Issue 9, 2012, Pages 983-985

  Luft, Friedrich C ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 210;

ARTICLE; GAP JUNCTION; GENE EXPRESSION; GENE THERAPY; HUMAN; MESENCHYMAL STEM CELL; NONHUMAN; RNA ANALYSIS; RNA DEGRADATION; RNA STRUCTURE;

ANIMALS; BASE SEQUENCE; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICRORNAS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; RATS;

EID: 84867336777     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-012-0933-9     Document Type: Article

References (9)

1. Zhu H, Fan G-C (2011) Role of microRNAs in the reperfused myocardium towards post-infarct remodeling. Cardiovasc Res 94:284-292
2. Huang X, Le Q-T, Giaccia AJ (2010) MiR-210-micromanager of the hypoxia pathway. Trends Mol Med 16:230-237
3. Chan YC, Banerjee J, Choi SY, Sen CK (2012) miR-210: the master hypoxamir. Microcirculation 19:215-223
4. Keeting A (2012) Mesenchymal stromal cells: new directions. Cell Stem Cell 10:709-716
5. Tan J, Wu W, Xu X, Liao L, Zheng F, Messinger S, Sun X, Chen J, Yang S, Cai J et al (2012) Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA 307:1169-1177
6. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, Gerstenblith G, DeMaria AN, Denktas AE, Gammon RS et al (2009) A randomized, double-blind, placebo-controlled, doseescalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 54:2277-2286
7. Bolli R, Chugh AR, D'Amario D, Loughran JH, Stoddard MF, Ikram S, Beache GM, Wagner SG, Leri A, Hosoda T et al (2011) Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 378:1847-1857
8. Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman D, Czer LS, Marbán L, Mendizabal A, Johnston PV et al (2012) Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 379:895-904
9. Kim HW, Jiang S, Ashraf M, Haider KH (2012) Stem-cell based delivery of hypoxamir-210 to the infarcted heart: implications on stem-cell survival and preservation of infarcted heart function. J Mol Med. doi:10.1007/s00109-012- 0920-1